Stock Research: Revvity

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Revvity

NYQ:RVTY US7140461093
87
  • Value
    94
  • Growth
    37
  • Safety
    Safety
    73
  • Combined
    87
  • Sentiment
    49
  • 360° View
    360° View
    87
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Revvity, Inc. provides health science solutions from discovery to cure. It operates in the life sciences and diagnostics industries. In the last fiscal year, the company had a market cap of $11,304 million, profits of $1,538 million, revenue of $2,755 million, and 11,000 employees.

more

ANALYSIS: With an Obermatt 360° View of 87 (better than 87% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Revvity are very positive. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Revvity. The consolidated Value Rank has an attractive rank of 94, which means that the share price of Revvity is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 94% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 73. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 49. Professional investors are more confident in 51% other stocks. The consolidated Growth Rank also has a low rank of 37, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 63 of its competitors have better growth. ...read more

more
Index
D.J. US Health Care
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Aug-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
94 93 98 97
Growth
37 35 5 19
Safety
Safety
73 66 38 64
Sentiment
49 47 42 31
360° View
360° View
87 85 36 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
26 42 31 30
Opinions Change
50 13 50 58
Pro Holdings
n/a 60 57 37
Market Pulse
31 76 55 54
Sentiment
49 47 42 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
94 93 98 97
Growth
37 35 5 19
Safety Safety
73 66 38 64
Combined
87 91 44 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
48 36 45 69
Price vs. Earnings (P/E)
44 59 64 57
Price vs. Book (P/B)
73 78 72 71
Dividend Yield
87 78 80 80
Value
94 93 98 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
25 38 16 5
Profit Growth
82 28 20 68
Capital Growth
27 31 44 16
Stock Returns
52 73 25 75
Growth
37 35 5 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
48 40 30 32
Refinancing
66 47 47 31
Liquidity
70 63 54 87
Safety Safety
73 66 38 64

Similar Stocks

Discover high‑ranked alternatives to Revvity and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Merck (USA)

NYQ:MRK
Country: USA
Industry: Pharmaceuticals
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: